1. 155PInter-rater reliability of programmed death ligand 1 (PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC). (23rd October 2018) Authors: Williams, G H; Nicholson, A G; Snead, D R J; Thunnissen, E; Lantuejoul, S; Cane, P; Kerr, K M; Loddo, M; Scott, M; Scorer, P W; Barker, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 80P Nintedanib (N) + docetaxel (D) after immunotherapy in adenocarcinoma non-small cell lung cancer (NSCLC): First results from the non-interventional LUME-BioNIS study. (15th December 2019) Authors: Reck, M; Syrigos, K; Miliauskas, S; Zöchbauer-Müller, S; Buchner, H; Kitzing, T; Kerr, K M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases. Issue 12 (December 1992) Authors: Carey, F A; Wallace, W A; Fergusson, R J; Kerr, K M; Lamb, D Journal: Thorax Issue: Volume 47:Issue 12(1992) Page Start: 1041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An audit of the clinical investigation of pleural effusion. Issue 9 (September 1992) Authors: Walshe, A D; Douglas, J G; Kerr, K M; McKean, M E; Godden, D J Journal: Thorax Issue: Volume 47:Issue 9(1992) Page Start: 734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Eosinophilic angiocentric fibrosis and Wegener's granulomatosis: a case report and literature review. Issue 8 (1st August 2001) Authors: Loane, J; Jaramillo, M; Young, H A; Kerr, K M Journal: Journal of clinical pathology Issue: Volume 54:Issue 8(2001) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura. Issue 10 (October 1997) Authors: Kennedy, A D; King, G; Kerr, K M Journal: Journal of clinical pathology Issue: Volume 50:Issue 10(1997) Page Start: 859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Histological appearances of putative montelukast related Churg–Strauss syndrome. Issue 12 (19th November 2008) Authors: Currie, G P; McKinlay, L; Kerr, K M Journal: Thorax Issue: Volume 63:Issue 12(2008) Page Start: 1120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Issue 6 (28th May 2004) Authors: Nicholson, A G; Addis, B J; Bharucha, H; Clelland, C A; Corrin, B; Gibbs, A R; Hasleton, P S; Kerr, K M; Ibrahim, N B N; Stewart, S; Wallace, W A H; Wells, A U Journal: Thorax Issue: Volume 59:Issue 6(2004) Page Start: 500 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Iron lung: bronchoscopic and pathological consequences of aspiration of ferrous sulphate. Issue 2 (February 1991) Authors: Godden, D J; Kerr, K M; Watt, S J; Legge, J S Journal: Thorax Issue: Volume 46:Issue 2(1991) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (15th June 2018) Authors: Haanen, J B A G; Carbonnel, F; Robert, C; Kerr, K M; Peters, S; Larkin, J; Jordan, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 4 Page Start: iv264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗